Affordable Access

Publisher Website

Personalized strategies for CML patients considering discontinuation of tyrosine kinase inhibitors treatment.

Authors
Type
Published Article
Journal
Leukemia Research
0145-2126
Publisher
Elsevier
Publication Date
Volume
36
Issue
9
Pages
1208–1209
Identifiers
DOI: 10.1016/j.leukres.2012.05.024
PMID: 22726921
Source
Medline

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments